horse red blood cells (Innovative Research Inc)
Innovative Research Inc is a verified supplier 
Innovative Research Inc manufactures this product 
90
Structured Review
Innovative Research Inc
horse red blood cells
Horse Red Blood Cells, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/horse+red+blood+cells/Horse+Red+Blood+Cells+Packed+10%25/pmc13085848-168-26-30
Average 90 stars, based on 2 article reviews
Horse Red Blood Cells, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/horse+red+blood+cells/Horse+Red+Blood+Cells+Packed+10%25/pmc13085848-168-26-30
Average 90 stars, based on 2 article reviews
horse red blood cells - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Incubation:Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection. Article Snippet: A modified HAI assay was performed as previously described.17,69 Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Article Title: Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice Article Snippet: .. Four hemagglutinin units of H7N9 reassortant influenza virus (HA and NA from A/Anhui/01/2013; other 6 segments from A/Puerto Rico/8/1934) were added to each well and the serum-virus mixture was incubated at 25°C for 1 h. Following incubation, 50 μL of 1% Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection Article Snippet: A modified HAI assay was performed as previously described., Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Virus:Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection. Article Snippet: A modified HAI assay was performed as previously described.17,69 Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Article Title: Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice Article Snippet: .. Four hemagglutinin units of H7N9 reassortant influenza virus (HA and NA from A/Anhui/01/2013; other 6 segments from A/Puerto Rico/8/1934) were added to each well and the serum-virus mixture was incubated at 25°C for 1 h. Following incubation, 50 μL of 1% Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection Article Snippet: A modified HAI assay was performed as previously described., Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Agglutination:Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection. Article Snippet: A modified HAI assay was performed as previously described.17,69 Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Article Title: Mosaic Inverted Hemagglutinin Extracellular Vesicle Vaccines Elicit Protective Systemic and Mucosal Immunity against Heterosubtypic Influenza Infection Article Snippet: A modified HAI assay was performed as previously described., Briefly, boost sera were treated with the receptor-destroying enzyme (RDE, Denka Seiken) at a 1:3 ratio and incubated at 37 °C overnight, followed by heat inactivation at 56 °C for 30 min. DPBS was then added to each sample to achieve a 1:10 dilution. .. The treated sera were serially 2-fold diluted and incubated with 4 HA units/25 μL of Aichi or PR8 virus for 30 min. 50 μL of 1.0% Saline:Article Title: Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice Article Snippet: .. Four hemagglutinin units of H7N9 reassortant influenza virus (HA and NA from A/Anhui/01/2013; other 6 segments from A/Puerto Rico/8/1934) were added to each well and the serum-virus mixture was incubated at 25°C for 1 h. Following incubation, 50 μL of 1% |